Beyond Body Size: Adiponectin as a Key Player in Obesity-Driven Cancers
- 24 October 2023
- journal article
- research article
- Published by Taylor & Francis in Nutrition and Cancer
- Vol. 75 (10) , 1848-1862
Abstract
Obesity, a complex and multifactorial disease influenced by genetic, environmental, and psychological factors, has reached epidemic proportions globally, posing a significant health challenge. In addition to its established association with cardiovascular disease and type II diabetes, obesity has been implicated as a risk factor for various cancers. However, the precise biological mechanisms linking obesity and cancer remain largely understood. Adipose tissue, an active endocrine organ, produces numerous hormones and bioactive molecules known as adipokines, which play a crucial role in metabolism, immune responses, and systemic inflammation. Notably, adiponectin (APN), the principal adipocyte secretory protein, exhibits reduced expression levels in obesity. In this scoping review, we explore and discuss the role of APN in influencing cancer in common malignancies, including lung, breast, colorectal, prostate, gastric, and endometrial cancers. Our review aims to emphasize the critical significance of investigating this field, as it holds great potential for the development of innovative treatment strategies that specifically target obesity-related malignancies. Furthermore, the implementation of more rigorous and comprehensive prevention and treatment policies for obesity is imperative in order to effectively mitigate the risk of associated diseases, such as cancer.Keywords
This publication has 131 references indexed in Scilit:
- Prognostic Effect of Circulating Adiponectin in a Randomized 2 × 2 Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women at Risk for Breast CancerJournal of Clinical Oncology, 2012
- Direct Role of Adiponectin and Adiponectin Receptors in Endometrial Cancer: In Vitro and Ex Vivo Studies in HumansMolecular Cancer Therapeutics, 2011
- Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer riskMetabolism, 2011
- Molecular mechanisms of leptin and adiponectin in breast cancerEuropean Journal of Cancer, 2011
- Expression of Leptin, Leptin Receptor, Adiponectin, and Adiponectin Receptor in Ductal CarcinomaIn Situand Invasive Breast CancerJournal of Breast Cancer, 2011
- T-cadherin is critical for adiponectin-mediated cardioprotection in miceJournal of Clinical Investigation, 2010
- Randomized Double-Blind 2 × 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal WomenJournal of Clinical Oncology, 2009
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003
- Mutation ofPten/Mmac1in mice causes neoplasia in multiple organ systemsProceedings of the National Academy of Sciences, 1999